Trial NCT03983824

View at ClinicalTrials.gov 
Org. Study IDs: NCI-2019-03607
Secondary IDs: 10273 NCI-2019-03607 PHI-103 UM1CA186717

Last trial update was posted on 2024-03-28

MeSH Interventions

Cytarabine Etoposide Etoposide phosphate Mitoxantrone Peposertib

MeSH Conditions

Leukemia Leukemia, Myeloid Leukemia, Myeloid, Acute

Other Conditions

Recurrent Acute Myeloid Leukemia Refractory Acute Myeloid Leukemia

Stopping Reasons

Scheduled Interim Monitoring

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID